49 Visits
• As of October 1, a vaccination campaign will be launched for children under 6 months of age. A single dose will be applied to all those born between April 1 and September 30 of this year Madrid, a pioneer region in Spain in start this immunization for newborns
The Governing Council of the Community of Madrid htoday approved the investment of 10.8 million euros for the acquisition of 50,000 doses of the vaccine that acts against the respiratory syncytial virus (RSV), which causes different clinical pictures, especially bronchiolitis and pneumonia.
So, As of October 1, an infant vaccination campaign will be launched, aimed at babies born between April 1 and September 30, 2023. The Community of Madrid thus becomes a pioneer region in Spain, along with Galicia, at the start of this immunization for newborns.
A dose
The monoclonal antibody against RSV is administered in a single dose that will be dispensed during the coming autumn-winter, coinciding with the increased circulation of this virus. It is the main cause of lower respiratory tract infections in children under one year of age, although it can also affect people over 65 and certain people at risk.
This type of conditions generates a significant number of consultations in Primary Care, especially in the autumn and winter months. In the Community of Madrid, during the past season 2022/23, se More than 18,000 pediatric emergencies due to bronchiolitis and 3,800 hospital admissions of infants under 12 months of age were recorded, with more than 300 stays in Intensive Care Units -ICU-.
2023-07-05 12:27:11
#Community #Madrid #acquires #doses #vaccine #immunizes #infants #bronchiolitis #Leganews #Comunicación
